Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 30;7(6):e640.
doi: 10.1212/NXG.0000000000000640. eCollection 2021 Dec.

White Matter Hyperintensities and Cerebral Microbleeds in Ataxia-Telangiectasia

Affiliations

White Matter Hyperintensities and Cerebral Microbleeds in Ataxia-Telangiectasia

May Yung Tiet et al. Neurol Genet. .

Abstract

Background and objectives: To systematically assess the occurrence of cerebral microbleeds (CMBs) and white matter hyperintensities (WMHs) in the largest published cohort of adults with ataxia-telangiectasia (AT).

Methods: We assessed 38 adults with AT (age range 18-55 years) including 15 classic and 23 variant AT, evaluated by two independent assessors. WMHs were quantified on T2-fluid attenuated inversion recovery images using the semiquantitative modified Scheltens and Fazekas scales and CMB on susceptibility-weighted imaging and T2*-weighted gradient echo sequences using the Brain Observer MicroBleed Scale.

Results: CMBs were more frequently found in classic AT compared with variant AT (66.7% vs 5.9%) predominantly in cortical and subcortical regions. WMHs were seen in 25 (73.5%) probands and CMBs in 9 (31.0%). The burden of WMHs increased with age, and WMHs were focused in periventricular and deep white matter regions. WMHs were more frequently seen in variant than classic AT.

Discussion: This cohort study confirms that WMHs and CMBs are a frequent finding in AT. Further longitudinal studies are required to understand how WMHs and CMBs relate to the neurodegeneration that occurs in AT and the predisposition to cerebral hemorrhage.

PubMed Disclaimer

Figures

Figure 1
Figure 1. White Matter Hyperintensities (Left) in a Patient With Variant AT at Age 22 Years; Cerebral Microbleeds (Right) in a Patient With Classic AT at Age 23 Years.
Figure 2
Figure 2. Heatmap Showing the Distribution of (A) White Matter Hyperintensities in Subjects With AT (Classic n = 12 and Variant n = 22). (B) Cerebral Microbleeds in Subjects With AT (Classic n = 12 and variant n = 17)
AT = ataxia-telangiectasia.

References

    1. Tiet MY, Horvath R, Hensiek AE. Ataxia telangiectasia: what the neurologist needs to know. Pract Neurol. 2020;20(5):404-414. - PubMed
    1. Low A, Mak E, Malpetti M, et al. . In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2021;92(1):45-52. - PMC - PubMed
    1. Scheltens P, Barkhof F, Leys D, et al. . A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci. 1993;114(1):7-12. - PubMed
    1. Cordonnier C, Potter GM, Jackson CA, et al. . Improving interrater agreement about brain microbleeds: Development of the Brain Observer MicroBleed Scale (BOMBS). Stroke. 2009;40(1):94-99. - PubMed
    1. Lin DD, Crawford TO, Lederman HM, Barker PB. Proton MR spectroscopic imaging in ataxia-telangiectasia. Neuropediatrics. 2006;37(4):241-246. - PubMed